Clinical Trial Update: Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases

View source ↗

Summary

A completed clinical trial evaluating the prebiotic effects of eicosapentaenoic acid (EPA) in colorectal cancer with liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Eicosapentaenoic acid (EPA) (eicosapentaenoic acid)

Snippet

Sponsor: University of Leeds | Conditions: Colon Cancer Liver Metastasis | Status: COMPLETED